Header cover image

Hong Kong (HSI) Biotech Industry Analysis

UpdatedMar 13, 2025
DataAggregated Company Financials
Companies49
  • 7D-0.4%
  • 3M11.7%
  • 1Y21.6%
  • YTD23.1%

Last week, the Biotech industry hasn't moved much but 3SBio is up 20% in that time. The past year has been better, since the industry has gained 22% in that time. As for the next few years, earnings are expected to grow by 44% per annum.

Industry Valuation and Performance

Has the Hong Kong Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 14 Mar 2025HK$448.4bHK$52.6b-HK$16,843,493,146.1921.7x-26.6x8.5x
Sun, 09 Feb 2025HK$377.0bHK$52.0b-HK$17,298,881,792.0113.7x-21.8x7.2x
Tue, 07 Jan 2025HK$367.7bHK$51.7b-HK$17,179,422,330.9111.8x-21.4x7.1x
Thu, 05 Dec 2024HK$399.2bHK$52.1b-HK$17,333,018,180.4711.1x-23x7.7x
Sat, 02 Nov 2024HK$390.8bHK$52.9b-HK$17,787,896,875.1311.3x-22x7.4x
Mon, 30 Sep 2024HK$384.6bHK$53.0b-HK$18,425,316,174.1611.9x-20.9x7.3x
Wed, 28 Aug 2024HK$337.3bHK$53.7b-HK$18,758,882,140.4711.2x-18x6.3x
Fri, 26 Jul 2024HK$312.5bHK$49.8b-HK$19,533,248,939.3111.8x-16x6.3x
Sun, 23 Jun 2024HK$332.5bHK$49.7b-HK$19,449,051,702.5611.4x-17.1x6.7x
Tue, 21 May 2024HK$371.0bHK$49.8b-HK$19,367,659,887.4612.2x-19.2x7.5x
Thu, 18 Apr 2024HK$324.1bHK$49.6b-HK$19,910,867,416.2410.7x-16.3x6.5x
Sat, 16 Mar 2024HK$366.5bHK$47.2b-HK$20,336,879,317.7117.6x-18x7.8x
Mon, 12 Feb 2024HK$321.6bHK$47.0b-HK$20,274,962,687.0915.5x-15.9x6.8x
Wed, 10 Jan 2024HK$378.5bHK$47.1b-HK$20,324,950,537.0017.6x-18.6x8x
Fri, 08 Dec 2023HK$403.9bHK$47.0b-HK$20,301,292,526.0017.5x-19.9x8.6x
Sun, 05 Nov 2023HK$413.3bHK$45.2b-HK$18,919,413,159.0012.9x-21.8x9.2x
Tue, 03 Oct 2023HK$400.6bHK$45.0b-HK$19,140,443,270.0013.9x-20.9x8.9x
Thu, 31 Aug 2023HK$392.2bHK$43.4b-HK$16,560,885,846.0015.1x-23.7x9x
Sat, 29 Jul 2023HK$427.6bHK$35.5b-HK$23,368,379,129.0028x-18.3x12x
Mon, 26 Jun 2023HK$386.4bHK$35.6b-HK$23,401,635,975.0024.1x-16.5x10.9x
Wed, 24 May 2023HK$436.6bHK$36.1b-HK$23,815,835,639.0030.1x-18.3x12.1x
Fri, 21 Apr 2023HK$443.5bHK$37.0b-HK$24,172,668,230.0018.6x-18.3x12x
Sun, 19 Mar 2023HK$405.8bHK$32.4b-HK$35,522,328,250.0022.9x-11.4x12.5x
Tue, 14 Feb 2023HK$445.5bHK$34.8b-HK$35,139,835,760.0031.5x-12.7x12.8x
Thu, 12 Jan 2023HK$441.8bHK$34.9b-HK$35,233,612,905.0029.6x-12.5x12.7x
Sat, 10 Dec 2022HK$392.8bHK$33.6b-HK$33,903,437,875.0024.6x-11.6x11.7x
Mon, 07 Nov 2022HK$356.4bHK$33.8b-HK$32,491,041,863.0018.5x-11x10.6x
Wed, 05 Oct 2022HK$286.6bHK$34.0b-HK$32,534,935,782.0017.3x-8.8x8.4x
Fri, 02 Sep 2022HK$335.0bHK$34.2b-HK$33,506,026,858.0015.7x-10x9.8x
Sun, 31 Jul 2022HK$328.6bHK$32.9b-HK$46,359,653,984.0013x-7.1x10x
Tue, 28 Jun 2022HK$381.5bHK$33.1b-HK$46,719,776,226.0014.7x-8.2x11.5x
Thu, 26 May 2022HK$321.4bHK$34.3b-HK$46,256,256,982.0012.8x-6.9x9.4x
Sat, 23 Apr 2022HK$332.4bHK$36.0b-HK$45,702,949,061.0012.9x-7.3x9.2x
Mon, 21 Mar 2022HK$324.3bHK$34.8b-HK$33,336,593,534.0013.2x-9.7x9.3x
Price to Earnings Ratio

-9.7x


Total Market Cap: HK$324.3bTotal Earnings: -HK$33,336,593,534.00Total Revenue: HK$34.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Hong Kong Biotech Industry Price to Earnings3Y Average -15.9x202320242025
Current Industry PE
  • Investors are relatively neutral on the Hong Kong Biotechs industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 9.2x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have improved over the last three years.
  • Revenues for these companies have grown 15% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Trends

Which industries have driven the changes within the Hong Kong Healthcare industry?

HK Market1.05%
Healthcare0.55%
Biotech-0.45%
Biotech-0.45%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
1530 3SBioHK$9.0320.4%
+HK$3.6b
70.1%PE12x
2142 HBM HoldingsHK$8.3023.9%
+HK$1.2b
435.5%PE36.5x
2315 Biocytogen Pharmaceuticals (Beijing)HK$13.6024.5%
+HK$1.1b
29.5%PS6.3x
2509 Qyuns TherapeuticsHK$10.5647.7%
+HK$757.3m
n/aPS36.6x
1672 Ascletis PharmaHK$7.566.5%
+HK$442.6m
361.0%PS672.2x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

1672

HK$7.56

Ascletis Pharma

7D

6.5%

1Y

361.0%

6990

HK$238.00

Sichuan Kelun-Biotech Biopharmaceutical

7D

-5.4%

1Y

54.7%

6660

HK$3.64

AIM Vaccine

7D

-31.3%

1Y

-57.1%

1801

HK$39.30

Innovent Biologics

7D

-2.6%

1Y

-5.0%

2142

HK$8.30

HBM Holdings

7D

23.9%

1Y

435.5%

1530

HK$9.03

3SBio

7D

20.4%

1Y

70.1%

2137

HK$2.57

Brii Biosciences

7D

26.6%

1Y

164.9%

9969

HK$8.73

InnoCare Pharma

7D

-9.7%

1Y

67.9%

9995

HK$15.68

RemeGen

7D

-12.4%

1Y

-41.6%

2315

HK$13.60

Biocytogen Pharmaceuticals (Beijing)

7D

24.5%

1Y

29.5%

775

HK$0.56

CK Life Sciences Int'l. (Holdings)

7D

3.7%

1Y

31.8%

2696

HK$29.10

Shanghai Henlius Biotech

7D

-7.5%

1Y

95.6%

2171

HK$13.10

CARsgen Therapeutics Holdings

7D

-18.1%

1Y

101.2%

1952

HK$51.45

Everest Medicines

7D

2.0%

1Y

86.8%

2509

HK$10.56

Qyuns Therapeutics

7D

47.7%

1Y

n/a

2563

HK$11.44

Beijing Biostar Pharmaceuticals

7D

-27.6%

1Y

n/a